Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation
Hui Cao, Xiaosong Chen, Zhijun Wang, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Abdul Basit Baba, Bilal Rah, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis
Boan Li, Fan Feng, Hui Jia, et al.
Food & Function (2021) Vol. 12, Iss. 6, pp. 2404-2417
Closed Access | Times Cited: 62
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
Xianlei Cai, Yunhao Chen, Da Man, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 60
ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation
Xiuyuan Zhang, Qijian Zheng, Xiuying Yue, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 40
Aldo-keto reductase family 1 member A1 (AKR1A1) exerts a protective function in alcohol-associated liver disease by reducing 4-HNE accumulation and p53 activation
Ying‐Wei Lan, Wanru Chen, Gary Ro‐Lin Chang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
The potential role of COVID-19 in the induction of DNA damage
Pablo Pánico, Patricia Ostrosky‐Wegman, Ana María Salazar
Mutation Research/Reviews in Mutation Research (2022) Vol. 789, pp. 108411-108411
Open Access | Times Cited: 31
AIEgen‐enhanced protein imaging: Probe design and sensing mechanisms
Sanaz Naghibi, Tong Chen, Amin Jamshidi Ghahfarokhi, et al.
Aggregate (2021) Vol. 2, Iss. 3
Closed Access | Times Cited: 39
Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement
Ahmed A. Mohamed, Randa A. Zaghloul, A. M. Abdelghany, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 4
Closed Access | Times Cited: 26
Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinib
Bei Zhang, Runsheng Chen, Xinqi Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion
Matthias Bartneck, Christiane Koppe, Viktor Fech, et al.
Cellular and Molecular Gastroenterology and Hepatology (2020) Vol. 11, Iss. 2, pp. 327-347
Open Access | Times Cited: 33
Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis
Yi Zhou, Guofei Cui, Hongwei Xu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 11
Ubiquitin: A double-edged sword in hepatitis B virus-induced hepatocellular carcinoma
Arpita Kar, Sandipan Mukherjee, Soumyadeep Mukherjee, et al.
Virology (2024) Vol. 599, pp. 110199-110199
Closed Access | Times Cited: 4
Biosynthesized Selenium-hydroxytyrosol nanoparticles attenuate hepatocellular carcinoma in rats
Radwa Tarek Tawfik, Eman M. Abd El-Azeem, Sawsan M. El-Sonbaty, et al.
Research Square (Research Square) (2025)
Closed Access
LARP3 inhibits the apoptosis of hepatocellular carcinoma via the ROS/PI3K/c-Fos axis
Lin Zhu, Qianqian Meng, Weiyi Qian, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317454-e0317454
Open Access
Mitochondrial dysfunction-driven AMPK-p53 axis activation underpins the anti-hepatocellular carcinoma effects of sulfane sulfur
Xue Zheng, Yuhua Luo, Rui Huo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Metabolomics Analysis of Functional Activity Changes in Residual Tumour Cells After IOCS Treatment
Lai-Wei You, Jinhuo Wang, Dan Yin, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 6
Open Access
Green-synthesized selenium-hydroxytyrosol nanocomposites attenuate hepatocellular carcinoma in rats by modulating oxidative stress, inflammation, and apoptosis
Radwa Tarek Tawfik, Eman M Abd El-Azeem, Sawsan M. El-Sonbaty, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Ubiquitin pathways regulate the pathogenesis of chronic liver disease
Jeong-Su Park, Hwan Ma, Yoon-Seok Roh
Biochemical Pharmacology (2021) Vol. 193, pp. 114764-114764
Closed Access | Times Cited: 26
Design and linkage optimization of ursane-thalidomide-based PROTACs and identification of their targeted-degradation properties to MDM2 protein
Zhiwen Qi, Yang Gu-liang, Tao Deng, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104901-104901
Closed Access | Times Cited: 25
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
Marc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101128-101128
Open Access | Times Cited: 3
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
Anabel Sánchez-Martín, Paula Sanchon-Sanchez, Marta R. Romero, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115209-115209
Open Access | Times Cited: 7
Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis
Mengzhi Wan, Qi Yu, Fei Xu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
Rui Liao, Lei Liu, Jian Zhou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top